Bundamedik Tbk vs Segar Kumala Indonesia Tbk — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Segar Kumala Indonesia Tbk trades at Rp520 (market cap 1.04T, 253.7K 24h volume). The key difference: Bundamedik Tbk is the larger of the two by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 253.7K). Which is the better fit depends on your goals.
| BMHS | BUAH | |
|---|---|---|
Market Cap | 1.51T | 1.04T |
Volume | 536.7K | 253.7K |
Lot | 5.37K | 2.54K |
Turnover | 93.41M | 130.28M |
Average Price | 174.05 | 513.52 |
Value | 93.41M | 130.28M |
Indicative Equilibrium Price | 176 | 520 |
Indicative Equilibrium Volume | 100 | 430 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →